Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;34(10):1298-1310.
doi: 10.1002/chir.23495. Epub 2022 Jul 26.

Advances and challenges in the pharmacokinetics and bioanalysis of chiral drugs

Affiliations
Review

Advances and challenges in the pharmacokinetics and bioanalysis of chiral drugs

V V S Prasanna Kumari Rayala et al. Chirality. 2022 Oct.

Abstract

Enantioselective analytical approaches are essential for monitoring pharmacokinetics and acquiring accurate data to better understand the role of stereochemistry in pharmacokinetics. Enantioselectivity significantly impacts the pharmacokinetics of chiral drugs, especially in metabolic profile, leading to toxicity of enantiomer. Consequently, there is a need to study the pharmacokinetics of enantiomerically pure drugs and racemates as they differ in affinity with enzymes and proteins. Combining the best enantioseparation conditions with the specified biological matrix and the intended purpose of the analysis is a challenging task. This review discusses the importance of chirality in stereoselective pharmacokinetics with more relevant examples, various enantioselective analytical techniques, and stationary phases employed. Challenges such as lack of universal chiral columns, biological inversion of the isomers, and others have been discussed. Further presented the recent advances in the screening of chiral drugs and innovative improvements in the analytical approaches for chiral molecule analysis such as supercritical fluid chromatography, simulated moving bed chromatography, and other techniques are discussed.

Keywords: bioanalysis; chiral drugs; chiral stationary phases; enantioselectivity; mass spectrometry; pharmacokinetics; supercritical fluid chromatography.

PubMed Disclaimer

References

REFERENCES

    1. Fujita S. Classification of stereoisomers. Flowcharts without and with the intermediate concept of RS-stereoisomers for mediating between enantiomers and stereoisomers. Tetrahedron: Asymmetry. 2016;27(1):43-62. doi:10.1016/j.tetasy.2015.11.005
    1. Kasprzyk-Hordern B. Pharmacologically active compounds in the environment and their chirality. Chem Soc Rev. 2010;39(11):4466-4503. doi:10.1039/c000408c
    1. Coelho MM, Fernandes C, Remião F, Tiritan ME. Enantioselectivity in drug pharmacokinetics and toxicity: pharmacological relevance and analytical methods. Molecules. 2021;26(11):3113. doi:10.3390/molecules26113113
    1. Ito T, Ando H, Handa H. Teratogenic effects of thalidomide: molecular mechanisms. Cell Mol Life Sci. 2011;68(9):1569-1579. doi:10.1007/s00018-010-0619-9
    1. Stirling DI. Pharmacology of thalidomide. Semin Hematol. 2000;37:5-14. doi:10.1016/S0037-1963(00)90077-5

MeSH terms

LinkOut - more resources